No abstract available
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Antineoplastic Agents, Alkylating / therapeutic use
-
Brain Neoplasms / diagnosis*
-
Brain Neoplasms / pathology
-
Brain Neoplasms / therapy*
-
Dacarbazine / analogs & derivatives
-
Dacarbazine / therapeutic use
-
Europe / epidemiology
-
Follow-Up Studies
-
Genetic Markers
-
Glioma / diagnosis*
-
Glioma / genetics
-
Glioma / pathology
-
Glioma / therapy*
-
Humans
-
Incidence
-
Loss of Heterozygosity
-
Neoplasm Staging
-
Prognosis
-
Radiotherapy
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Secondary Prevention
-
Temozolomide
-
Treatment Outcome
Substances
-
Adrenal Cortex Hormones
-
Antineoplastic Agents, Alkylating
-
Genetic Markers
-
Dacarbazine
-
Temozolomide